A total of 74 MBq of [89Zr]Zr(Ox)2 in 1 M oxalic acid (Sylvia Fedoruk Canadian Centre for Nuclear Innovation, Saskatoon, SK, Canada) was dissolved in 0.5 M HEPES buffer (which was previously passed through a Chelex-100 column to remove any trace metals) and neutralized using 1M Na2CO3. A total of 400 µg of IF3-DFO was then added to achieve a 0.185:1 MBq:µg specific activity. The reaction mixture was heated at 37° for 1 h and then quenched using 3 µL of 0.05 M DTPA solution; the percentage of radiolabeling yield was measured with instant thin layer chromatography (iTLC) (Agilent Technologies, Santa Clara, CA, USA) using 0.5 M EDTA as the eluant. The iTLC was cut in half and measured using a 2470 Wizard2 Gamma counter (Perkin Elmer, Waltham, MA, USA) calibrated for 89Zr emission spectra. Radiolabeling yields were calculated by dividing the counts per minute at the bottom half of the iTLC CPM by the total counts per minute (top + bottom), as the labeled antibody has a Rf = 0 vs. Rf = 1 for [89Zr]Zr-DTPA/EDTA. Radiolabeling yields were greater than 99%. The radiolabeled antibody was then exchanged into sterile phosphate-buffered saline (PBS) prior to injection.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.